WorldHeart To Pursue New Trial Against Abiomed Following Jury Verdict
This article was originally published in The Gray Sheet
WorldHeart Corp. says it will file another complaint against Abiomed following a Feb. 4 jury verdict in Delaware federal court finding the left ventricular assist device manufacturer not guilty of breach of contract and misappropriation of trade secrets.
You may also be interested in...
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.
Developing biosimilar orphan drugs is fraught with challenges and needs buy-in from regulators, developers, patients and clinicians.